Primrose / Cowslip

Metadata

Approved Indications

German Commission E

• Primula root: Productive cough, catarrh of the respiratory tract
• Sinupret combination (approved 1994): Acute and chronic inflammation of the paranasal sinuses

ESCOP

• Primula root: Productive cough, catarrh of the airways, chronic bronchitis
• Primula flower: Catarrh of the respiratory tract

EMA/HMPC

• Traditional use: Relief of symptoms of common cold
• Monograph covers both root and flower preparations

Agreement/Disagreement Between Bodies

Good agreement on productive cough and respiratory catarrh. The Sinupret combination has its own regulatory approval separate from single-herb Primula monographs. ESCOP is slightly broader, explicitly mentioning chronic bronchitis.

Conditions Treated

As Monotherapy (Primula veris)

• Productive cough
• Respiratory catarrh
• Chronic bronchitis (supportive)

As Sinupret Combination (BNO 1016)

• Acute rhinosinusitis (primary RCT indication)
• Chronic rhinosinusitis (some evidence, less robust)
• Acute and chronic inflammation of the paranasal sinuses

As Bronchipret Combination (with Thyme)

• Acute bronchitis with productive cough

Mechanism of Action

Primula veris (Single Herb)

1. Secretolytic/Expectorant: Saponins (primula acid glycosides) stimulate gastric mucosa reflexly, increasing bronchial secretion via the vagal pathway. This thins and loosens viscous mucus.
2. Mucolytic: Direct reduction of mucus viscosity
3. Anti-inflammatory: Flavonoids and phenolic acids contribute to anti-inflammatory effects
4. Antimicrobial: Modest antibacterial activity
5. Antioxidant: Phenolic compounds provide antioxidant protection

Key active constituents:

• Triterpene saponins (primula acid I and II) — primary expectorant compounds
• Flavonoids (rutin, quercetin)
• Phenolic acids (caffeic acid, chlorogenic acid)
• Essential oil (small amounts)

Sinupret (BNO 1016) — Combination Mechanism

Sinupret contains 5 herbal extracts working synergistically:

Synergistic effects of the combination:

• Antiviral activity against adenovirus, human rhinovirus, RSV, parainfluenza virus (demonstrated in vitro)
• Enhanced mucociliary clearance through multiple complementary mechanisms
• Anti-inflammatory effects through multiple pathways

Clinical Evidence Summary

Sinupret (BNO 1016) — Acute Rhinosinusitis

Virgin et al. (2015) — Pivotal RCT

• Design: Randomized, double-blind, placebo-controlled
• Population: 386 patients with acute viral rhinosinusitis
• Intervention: Sinupret extract 160 mg (equivalent to 480 mg BNO 1016), 2 tablets 3 times daily for 15 days
• Primary outcome: Major Symptom Score (MSS)
• Results:
  • MSS reduction: 1.9 points more than placebo (p < 0.0001)
  • SNOT-20 quality of life: 3.5 points improvement over placebo (p = 0.001)
  • Healing rate: 48.4% vs. 35.8% placebo (p = 0.0063)
  • In moderate/severe subgroup: MSS reduction of 2.3 points (p < 0.0001)
• [Source: PMC 4487568]

Systematic Review (Poecheim & Germann, 2006)

• Systematic review of clinical data with BNO-101
• Supported efficacy and safety in acute sinusitis
• [Source: PubMed 16645287]

Sinupret — Chronic Rhinosinusitis

• RCT in chronic rhinosinusitis: Primary endpoint not met, but secondary endpoints showed trend toward superior efficacy over placebo
• [UNCERTAIN: Chronic sinusitis evidence is weaker than acute sinusitis evidence]

Bronchipret (Thyme + Primrose) — Acute Bronchitis

• See detailed evidence in Thyme
• Key result: 50% reduction in coughing fits reached 2 days earlier than placebo (n=361)

Sinupret — Olfactory Function

• A study showed Sinupret may improve olfactory function in patients with sinonasal olfactory dysfunction
• [Source: PubMed 21858267]

Evidence Assessment

Sinupret is notable as the sole herbal product for rhinosinusitis with evidence from well-designed, adequately powered RCTs. This places it in a unique category among herbal sinus remedies.

European vs. US/Anglophone Consensus

Safety Profile

Contraindications

• Hypersensitivity to primrose or any component
• Sinupret: Hypersensitivity to any of the 5 herbal components
• Active gastric ulcer (saponins may irritate gastric mucosa at high doses)

Drug Interactions

• No known drug interactions reported for Sinupret or primrose monotherapy
• No formal interaction studies available [NEEDS-RESEARCH]

Side Effects

• Gastrointestinal: Nausea, stomach discomfort (uncommon; due to saponin content)
• Allergic: Rare skin reactions
• Sinupret: Overall well-tolerated; adverse events are uncommon and mild
• Important: Not to be confused with Evening Primrose (Oenothera biennis), which is an entirely different plant with different safety considerations

Pregnancy and Lactation

• Pregnancy: Not recommended due to insufficient safety data (per EMA)
• Lactation: Not recommended due to insufficient data
• Sinupret: Not recommended in pregnancy/lactation as a precaution

Clinical Dosage

Sinupret Extract (BNO 1016)

Sinupret Forte (older formulation)

Primrose Root (Monotherapy)

Sources

• German Commission E: Primulae radix monograph (1990); Sinupret combination approval (1994)
• ESCOP Monograph: Primulae radix
• EMA/HMPC Assessment: Primula veris
• Virgin et al. (2015). PMC 4487568.
• Poecheim & Germann (2006). PubMed 16645287.
• Bionorica: Sinupret and Bronchipret product information.
• Altmeyers Encyclopedia: Primula flos entry.
• ScienceDirect: Sinupret overview topic.
• WebMD: Cowslip overview.

Connections

• Key combination partner with Thyme (Bronchipret TP)
• Contains Elderflower (Sambucus nigra) as a Sinupret component
• Compare sinusitis evidence with Myrtol Standardized (GeloMyrtol, also used for sinusitis)
• Compare sinusitis evidence with Eucalyptus (cineole for sinusitis)